Literature DB >> 25070237

Soft tissue sarcomas.

Andre Spiguel1.   

Abstract

Sarcoma is a cancer that arises from cells of mesenchymal origin, such as bone, cartilage, muscle, fat, vascular, or hematopoietic tissue. It is a very rare form of cancer with over 50 histologic subtypes. This chapter discusses selected individual subtypes of sarcomas and characteristics specific to each one. It will broadly go over molecular biology, etiology, risk factors, and the clinical features of this disease. It discusses diagnostic evaluation and the principles of management including imaging, biopsy, staging, treatment, follow-up, and the importance of a multidisciplinary approach.

Entities:  

Mesh:

Year:  2014        PMID: 25070237     DOI: 10.1007/978-3-319-07323-1_10

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  7 in total

1.  Aggressive fibromatosis of the leg and sacrococcygeal region: a report of two cases.

Authors:  Fuwen Pan; Qiang Liu; Guoru Zhang; Qiqi Wang; Bo Yun; Yaoguang Han; Rui Deng; Linqing Wu; Shihua Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 2.  Comparative oncology: what dogs and other species can teach us about humans with cancer.

Authors:  Joshua D Schiffman; Matthew Breen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

3.  Spatial Outcomes of Soft Tissue Sarcoma in Southern West Virginia.

Authors:  Frank H Annie; Christopher K Uejio; Sarah Embrey
Journal:  Cureus       Date:  2020-11-12

4.  The prognostic factors of primary colorectal sarcoma and the clinical outcomes of negative lymph node dissection.

Authors:  Zhewen Wei; Rui Mao; Yefan Zhang; Xinyu Bi; Jianguo Zhou; Zhiyu Li; Zhen Huang; Xiao Chen; Jianjun Zhao; Hong Zhao; Jianqiang Cai
Journal:  Ann Transl Med       Date:  2021-02

5.  Pulmonary metastasectomy in bone and soft tissue sarcoma with metastasis to the lung.

Authors:  Charles A Gusho; Christopher W Seder; Nicolas Lopez-Hisijos; Alan T Blank; Marta Batus
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-11-22

6.  The benefit of everolimus in recurrent/epithelioid angiosarcoma patients: Case reports and literature review.

Authors:  Shi-Long Zhang; Li Liang; Yuan Ji; Zhi-Ming Wang; Yu-Hong Zhou
Journal:  Oncotarget       Date:  2017-10-15

7.  Impact of the Activation Status of the Akt/mTOR Signalling Pathway on the Clinical Behaviour of Synovial Sarcoma: Retrospective Analysis of 174 Patients at a Single Institution.

Authors:  Ying-Xue Li; Shan-Shan Ding; Wen-Juan Wen; Lin Han; Hong-Qun Wang; Huai-Yin Shi
Journal:  Cancer Manag Res       Date:  2020-03-09       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.